Inventor
HAGERTY DAVID
US9 patents
⚠️ This page may combine multiple inventors who share the name “HAGERTY DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
6 patentsUS7455835B2Nov 25, 2008
Methods for treating immune system diseases using a soluble CTLA4 molecule
BRISTOL MYERS SQUIBB CO57 citations96
US8722632B2May 13, 2014
Methods for treating Sjogrens syndrome by administering a soluble CTLA4 molecule
BRISTOL MYERS SQUIBB CO9 citations91
US7482327B2Jan 27, 2009
Methods for treating immune disorders associated with graft transplantation with soluble CTLA4 mutant molecules
BRISTOL MYERS SQUIBB CO23 citations89
US9296808B2Mar 29, 2016
Methods for treating scleroderma by administering a soluble CTLA4 molecule
BRISTOL MYERS SQUIBB CO7 citations83
US8703718B2Apr 22, 2014
Methods for treating juvenile rheumatoid arthritis by administering a soluble CTLA4 molecule
BRISTOL MYERS SQUIBB CO7 citations83
US10052360B2Aug 21, 2018
Methods for treating dermatomyositis or polymyositis by administering a soluble CTLA4 molecule
BRISTOL MYERS SQUIBB CO2 citations72
COHEN ROBERT
3 patentsUS8497247B2Jul 30, 2013
Methods for treating type I diabetes mellitus by administering a soluble CTLA4 molecule
COHEN ROBERT15 citations91
US8227420B2Jul 24, 2012
Method for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID
COHEN ROBERT10 citations91
US8148332B2Apr 3, 2012
Method for treating a rheumatic disease using a soluble TLA4 molecule
COHEN ROBERT9 citations91